These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 32523646

  • 1. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH.
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [Abstract] [Full Text] [Related]

  • 2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y, Wu T, Hu X, Wang T.
    Eur J Phys Rehabil Med; 2017 Apr 31; 53(2):256-267. PubMed ID: 27834471
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct 31; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Oct 31; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 31; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke.
    Takekawa T, Kakuda W, Taguchi K, Ishikawa A, Sase Y, Abo M.
    Int J Rehabil Res; 2012 Jun 31; 35(2):146-52. PubMed ID: 22453625
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.
    Eur J Neurol; 2001 Nov 31; 8(6):559-65. PubMed ID: 11784339
    [Abstract] [Full Text] [Related]

  • 15. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct 31; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.